絞り込み

16314

広告

アジア各地に邦楽の公演可能なライブホール開設を発表

大手音楽会社のソニー・ミュージックエンタテインメントとそのグループ会社は、官民ファンドの支援を受けて、アジア各地に日本のアーティストなどが公演を行えるライブホー...

  1. ヒートショックプロテインを増やす入浴法 ...
  2. 痛風対策してますか?食事・運動・サプリメ...
  3. 英エコノミスト誌が予測「日本は人口減少で...
  4. 高浜原発4号機 燃料入れる作業始まる 来...

ニュース一覧

「elotuzumab」の検索結果

133件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Which therapies will move to the front line for multiple myeloma?

Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.

How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?

Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysis.

Immunotherapy for the treatment of multiple myeloma.

Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.

FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma.

A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 hour, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.

Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes.

Optimizing current and emerging therapies in multiple myeloma: a guide for the hematologist.

Immune Therapies in Multiple Myeloma.

Progress and Paradigms in Multiple Myeloma.

Safety issues and managment of toxicities associated with new treatments for multiple myeloma.

Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials.

An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab.

Efficacy and safety of elotuzumab for the treatment of multiple myeloma.

Phase I trial of elotuzumab, lenalidomide, and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma.

Elotuzumab with lenalidomide and low-dose dexamethasone in patients with relapsed multiple myeloma: A randomized phase II study.

The effect of elotuzumab on natural killer (NK) cell function against multiple myeloma (MM).

How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple Myeloma.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
Sort by
※並べ替えは表示に時間がかかります